Complement Potentiates Immune Sensing of HIV-1 and Early Type I Interferon Responses

Importantly, our study highlights an unusual target on DCs—the α chain of complement receptor 4 (CR4) (CD11c)—for therapeutic interventions in HIV-1 treatment. Targeting CD11c on DCs mediated a potent antiviral immune response via clustering of CR4 and CCR5 and subsequent opening of an antiviral re...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wilfried Posch, Marta Bermejo-Jambrina, Marion Steger, Christina Witting, Gabriel Diem, Paul Hörtnagl, Hubert Hackl, Cornelia Lass-Flörl, Lukas A. Huber, Teunis B. H. Geijtenbeek, Doris Wilflingseder
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://doaj.org/article/6bf2a44de32345d8b59615a811b9661a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6bf2a44de32345d8b59615a811b9661a
record_format dspace
spelling oai:doaj.org-article:6bf2a44de32345d8b59615a811b9661a2021-11-03T21:52:35ZComplement Potentiates Immune Sensing of HIV-1 and Early Type I Interferon Responses2150-751110.1128/mBio.02408-21https://doaj.org/article/6bf2a44de32345d8b59615a811b9661a2021-10-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.02408-21https://doaj.org/toc/2150-7511 Importantly, our study highlights an unusual target on DCs—the α chain of complement receptor 4 (CR4) (CD11c)—for therapeutic interventions in HIV-1 treatment. Targeting CD11c on DCs mediated a potent antiviral immune response via clustering of CR4 and CCR5 and subsequent opening of an antiviral recognition pathway in DCs via MAVS.Wilfried PoschMarta Bermejo-JambrinaMarion StegerChristina WittingGabriel DiemPaul HörtnaglHubert HacklCornelia Lass-FlörlLukas A. HuberTeunis B. H. GeijtenbeekDoris WilflingsederAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 12, Iss 5 (2021)
institution DOAJ
collection DOAJ
language EN
topic Microbiology
QR1-502
spellingShingle Microbiology
QR1-502
Wilfried Posch
Marta Bermejo-Jambrina
Marion Steger
Christina Witting
Gabriel Diem
Paul Hörtnagl
Hubert Hackl
Cornelia Lass-Flörl
Lukas A. Huber
Teunis B. H. Geijtenbeek
Doris Wilflingseder
Complement Potentiates Immune Sensing of HIV-1 and Early Type I Interferon Responses
description Importantly, our study highlights an unusual target on DCs—the α chain of complement receptor 4 (CR4) (CD11c)—for therapeutic interventions in HIV-1 treatment. Targeting CD11c on DCs mediated a potent antiviral immune response via clustering of CR4 and CCR5 and subsequent opening of an antiviral recognition pathway in DCs via MAVS.
format article
author Wilfried Posch
Marta Bermejo-Jambrina
Marion Steger
Christina Witting
Gabriel Diem
Paul Hörtnagl
Hubert Hackl
Cornelia Lass-Flörl
Lukas A. Huber
Teunis B. H. Geijtenbeek
Doris Wilflingseder
author_facet Wilfried Posch
Marta Bermejo-Jambrina
Marion Steger
Christina Witting
Gabriel Diem
Paul Hörtnagl
Hubert Hackl
Cornelia Lass-Flörl
Lukas A. Huber
Teunis B. H. Geijtenbeek
Doris Wilflingseder
author_sort Wilfried Posch
title Complement Potentiates Immune Sensing of HIV-1 and Early Type I Interferon Responses
title_short Complement Potentiates Immune Sensing of HIV-1 and Early Type I Interferon Responses
title_full Complement Potentiates Immune Sensing of HIV-1 and Early Type I Interferon Responses
title_fullStr Complement Potentiates Immune Sensing of HIV-1 and Early Type I Interferon Responses
title_full_unstemmed Complement Potentiates Immune Sensing of HIV-1 and Early Type I Interferon Responses
title_sort complement potentiates immune sensing of hiv-1 and early type i interferon responses
publisher American Society for Microbiology
publishDate 2021
url https://doaj.org/article/6bf2a44de32345d8b59615a811b9661a
work_keys_str_mv AT wilfriedposch complementpotentiatesimmunesensingofhiv1andearlytypeiinterferonresponses
AT martabermejojambrina complementpotentiatesimmunesensingofhiv1andearlytypeiinterferonresponses
AT marionsteger complementpotentiatesimmunesensingofhiv1andearlytypeiinterferonresponses
AT christinawitting complementpotentiatesimmunesensingofhiv1andearlytypeiinterferonresponses
AT gabrieldiem complementpotentiatesimmunesensingofhiv1andearlytypeiinterferonresponses
AT paulhortnagl complementpotentiatesimmunesensingofhiv1andearlytypeiinterferonresponses
AT huberthackl complementpotentiatesimmunesensingofhiv1andearlytypeiinterferonresponses
AT cornelialassflorl complementpotentiatesimmunesensingofhiv1andearlytypeiinterferonresponses
AT lukasahuber complementpotentiatesimmunesensingofhiv1andearlytypeiinterferonresponses
AT teunisbhgeijtenbeek complementpotentiatesimmunesensingofhiv1andearlytypeiinterferonresponses
AT doriswilflingseder complementpotentiatesimmunesensingofhiv1andearlytypeiinterferonresponses
_version_ 1718445401569230848